These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36183420)

  • 41. Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.
    Shea YF; Ha J; Chu LW
    Psychogeriatrics; 2015 Dec; 15(4):235-41. PubMed ID: 25533477
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
    Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
    Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies.
    Mulugeta E; Londos E; Ballard C; Alves G; Zetterberg H; Blennow K; Skogseth R; Minthon L; Aarsland D
    J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):160-4. PubMed ID: 21047883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies.
    Bongianni M; Ladogana A; Capaldi S; Klotz S; Baiardi S; Cagnin A; Perra D; Fiorini M; Poleggi A; Legname G; Cattaruzza T; Janes F; Tabaton M; Ghetti B; Monaco S; Kovacs GG; Parchi P; Pocchiari M; Zanusso G
    Ann Clin Transl Neurol; 2019 Oct; 6(10):2120-2126. PubMed ID: 31599499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.
    Chaudhry A; Houlden H; Rizig M
    J Neurol Sci; 2020 Aug; 415():116886. PubMed ID: 32428759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. alpha-Synuclein antibodies recognize a protein present at lower levels in the CSF of patients with dementia with Lewy bodies.
    Ballard C; Jones EL; Londos E; Minthon L; Francis P; Aarsland D
    Int Psychogeriatr; 2010 Mar; 22(2):321-7. PubMed ID: 19747426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic value of cerebrospinal fluid alpha-synuclein in dementia with Lewy body.
    Bousiges O; Blanc F
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Sep; 16(3):305-310. PubMed ID: 30168437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concomitant AD pathology affects clinical manifestation and survival in dementia with Lewy bodies.
    Lemstra AW; de Beer MH; Teunissen CE; Schreuder C; Scheltens P; van der Flier WM; Sikkes SA
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):113-118. PubMed ID: 27794030
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diagnostic value of CSF α-synuclein in the differential diagnosis of dementia with Lewy bodies vs. normal subjects and patients with Alzheimer's disease.
    Kapaki E; Paraskevas GP; Emmanouilidou E; Vekrellis K
    PLoS One; 2013; 8(11):e81654. PubMed ID: 24282614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
    Hall S; Surova Y; Öhrfelt A; ; Blennow K; Zetterberg H; Hansson O
    Mov Disord; 2016 Jun; 31(6):898-905. PubMed ID: 26878815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The combined effect of amyloid-β and tau biomarkers on brain atrophy in dementia with Lewy bodies.
    Abdelnour C; Ferreira D; Oppedal K; Cavallin L; Bousiges O; Wahlund LO; Hort J; Nedelska Z; Padovani A; Pilotto A; Bonanni L; Kramberger MG; Boada M; Westman E; Pagonabarraga J; Kulisevsky J; Blanc F; Aarsland D
    Neuroimage Clin; 2020; 27():102333. PubMed ID: 32674011
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.
    Baiardi S; Quadalti C; Mammana A; Dellavalle S; Zenesini C; Sambati L; Pantieri R; Polischi B; Romano L; Suffritti M; Bentivenga GM; Randi V; Stanzani-Maserati M; Capellari S; Parchi P
    Alzheimers Res Ther; 2022 Oct; 14(1):153. PubMed ID: 36221099
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Amyloid pathology influences aβ1-42 cerebrospinal fluid levels in dementia with lewy bodies.
    Slaets S; Le Bastard N; Theuns J; Sleegers K; Verstraeten A; De Leenheir E; Luyckx J; Martin JJ; Van Broeckhoven C; Engelborghs S
    J Alzheimers Dis; 2013; 35(1):137-46. PubMed ID: 23364139
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients.
    Wennström M; Hall S; Nägga K; Londos E; Minthon L; Hansson O
    Alzheimers Res Ther; 2015 Oct; 7(1):63. PubMed ID: 26434635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations of sleep characteristics with alpha-synuclein in cerebrospinal fluid in older adults.
    Wang XT; Liu FT; Bi YL; Shen XN; Xu W; Wang J; Tan L; Yu JT
    Ann Clin Transl Neurol; 2020 Oct; 7(10):2026-2034. PubMed ID: 32949229
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic value of Alzheimer's biomarkers in cerebrospinal fluid in dementia with Lewy body.
    Bousiges O; Blanc F
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Jun; 16(2):174-180. PubMed ID: 29877185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Total tau protein, phosphorylated tau (181p) protein, beta-amyloid(1-42), and beta-amyloid(1-40) in cerebrospinal fluid of patients with dementia with Lewy bodies.
    Mollenhauer B; Bibl M; Wiltfang J; Steinacker P; Ciesielczyk B; Neubert K; Trenkwalder C; Otto M
    Clin Chem Lab Med; 2006; 44(2):192-5. PubMed ID: 16475906
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies.
    Bibl M; Mollenhauer B; Esselmann H; Lewczuk P; Trenkwalder C; Brechlin P; Rüther E; Kornhuber J; Otto M; Wiltfang J
    J Neural Transm (Vienna); 2006 Nov; 113(11):1771-8. PubMed ID: 16906356
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Applying the Alzheimer Disease ATN Diagnostic Framework in Atypical Dementia.
    Funnell C; Feldman HH; Mackenzie IRA; DeMarco ML
    Alzheimer Dis Assoc Disord; 2020; 34(4):357-359. PubMed ID: 33215886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.